[Usefulness of the Tornus® catheter in nondilatable coronary chronic total occlusion]

Rev Esp Cardiol. 2011 Oct;64(10):935-8. doi: 10.1016/j.recesp.2011.01.011. Epub 2011 Jun 12.
[Article in Spanish]

Abstract

The treatment of coronary chronic total occlusions (CTO) remains a challenge for the interventional cardiologist. Failure of balloon angioplasty is the second more common cause of an unsuccessful procedure. We describe our experience with the use of the new Tornus® catheter (Asahi Intecc, Aichi, Japan) designed specifically for the treatment of "nondilatable" CTO. Between November 2008 and March 2010, 17 patients (age 62 years, 88% men, 82% dyslipidemia, 52% hypertension, 29% diabetes) were treated in whom balloon dilatation had failed after crossing the lesion with the guide. The use of Tornus® catheter was successful without complications in 15. All patients underwent clinical follow-up (median, 573 days) with no documented major adverse events. The use of the Tornus® catheter is safe and feasible in those patients with CTO lesions in whom balloon angioplasty has been unsuccessful.

MeSH terms

  • Aged
  • Cardiac Catheterization / methods*
  • Catheterization
  • Catheters*
  • Clopidogrel
  • Coronary Angiography
  • Coronary Occlusion / therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Revascularization / methods*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Stents
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use
  • Treatment Failure

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine